Pfizer Inc. buy Guggenheim
Start price
17.12.25
/
50%
€21.74
Target price
17.12.26
-
Performance (%)
-0.16%
Price
31.07.26
€21.71
Summary
This prediction is currently active. Since the start of the prediction for Pfizer Inc. the price has only changed by -0.16%. This prediction currently runs until 17.12.26. The prediction end date can be changed by Guggenheim at any time. Guggenheim has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Pfizer Inc. | 0.533% | 0.533% |
| iShares Core DAX® | 2,59 % | 2,69 % |
| iShares Nasdaq 100 | -0,91 % | -7,37 % |
| iShares Nikkei 225® | 0,15 % | -10,20 % |
| iShares S&P 500 | -0,37 % | -0,83 % |
Comments by Guggenheim for this prediction
In the thread Pfizer Inc. diskutieren
Pfizer (NYSE:PFE) had its "buy" rating reaffirmed by analysts at Guggenheim.
Ratings data for PFE provided by MarketBeat